Infliximab use in Crohn's disease: impact on health care resources in the UK.
OBJECTIVE: To quantify the impact of infliximab therapy on health care resource utilization in the UK. METHODS: A retrospective audit was undertaken at seven centres in the UK, which reviewed patient notes for a period of 6 months before and 6 months after an initial infliximab infusion. Details of...
المؤلفون الرئيسيون: | Jewell, D, Satsangi, J, Lobo, A, Probert, C, Forbes, A, Ghosh, S, Shaffer, J, Frenz, M, Drummond, H, Troy, G, Turner, S, Younge, L, Evans, L, Moosa, M, Rodgers-Gray, B, Buchan, S |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2005
|
مواد مشابهة
-
Infliximab in Crohn's disease
حسب: L. Rodrigo Sáez -
Infliximab in the Treatment of Crohn’s Disease
حسب: Brian Feagan
منشور في: (2000-01-01) -
Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
حسب: Hyder, SA, وآخرون
منشور في: (2006) -
Molecular genetics of Crohn's disease: recent advances.
حسب: Satsangi, J, وآخرون
منشور في: (1998) -
Predictors of response to infliximab in patients with fistulizing Crohn's disease Factores predictivos de respuesta a infliximab en pacientes con enfermedad de Crohn fistulizante
حسب: M. Luna-Chadid, وآخرون
منشور في: (2004-06-01)